$53.69
-1.86 (-3.35%)
Performance
1D
+0.00%
1W
-13.45%
1M
-13.42%
3M
-30.71%
6M
-27.99%
1Y
-10.75%
YTD
-13.02%
Open$55.70
Previous Close$55.55
Day High$56.51
Day Low$53.55
52W High$88.31
52W Low$54.16
Volume—
Avg Volume1.98M
Market Cap7.59B
P/E Ratio—
EPS$-7.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$65.67
Below
SMA 200
$69.97
Below
RSI (14)
28
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
28 analysts
Price Target
+48.6% upside
Current
$53.69
$53.69
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 103.64M | 106.16M | 617.31M |
| Net Income | -924,100,261 | -851,879,785 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -851,608,225 | -828,667,227 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |